These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 11153576

  • 1. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.
    Bousquet J, D'Urzo A, Hebert J, Barraza CH, Boulet LP, Suárez-Chacón R, Harnest U, Lundbäck B, Martinez Morales G, Nieminen MM, Nolop KB, Visser S, Lutsky BN.
    Eur Respir J; 2000 Nov; 16(5):808-16. PubMed ID: 11153576
    [Abstract] [Full Text] [Related]

  • 2. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
    O'Connor B, Bonnaud G, Haahtela T, Luna JM, Querfurt H, Wegener T, Lutsky BN.
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
    [Abstract] [Full Text] [Related]

  • 3. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.
    Corren J, Berkowitz R, Murray JJ, Prenner B.
    Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054
    [Abstract] [Full Text] [Related]

  • 4. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
    Bernstein DI, Berkowitz RB, Chervinsky P, Dvorin DJ, Finn AF, Gross GN, Karetzky M, Kemp JP, Laforce C, Lumry W, Mendelson LM, Nelson H, Pearlman D, Rachelefsky G, Ratner P, Repsher L, Segal AT, Selner JC, Settipane GA, Wanderer A, Cuss FM, Nolop KB, Harrison JE.
    Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973
    [Abstract] [Full Text] [Related]

  • 5. Mometasone furoate dry-powder inhaler for the control of persistent asthma.
    D'Urzo A.
    Expert Opin Pharmacother; 2007 Nov; 8(16):2871-84. PubMed ID: 17956206
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG.
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [Abstract] [Full Text] [Related]

  • 7. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.
    Kemp JP, Berkowitz RB, Miller SD, Murray JJ, Nolop K, Harrison JE.
    J Allergy Clin Immunol; 2000 Sep; 106(3):485-92. PubMed ID: 10984368
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A, Karpel JP, Busse WW, Boulet LP, Monahan ME, Lutsky B, Staudinger H.
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [Abstract] [Full Text] [Related]

  • 9. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
    Karpel JP, Busse WW, Noonan MJ, Monahan ME, Lutsky B, Staudinger H.
    Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
    [Abstract] [Full Text] [Related]

  • 10. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
    Berger WE, Milgrom H, Chervinsky P, Noonan M, Weinstein SF, Lutsky BN, Staudinger H.
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
    [Abstract] [Full Text] [Related]

  • 11. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.
    Nathan RA, Nayak AS, Graft DF, Lawrence M, Picone FJ, Ahmed T, Wolfe J, Vanderwalker ML, Nolop KB, Harrison JE.
    Ann Allergy Asthma Immunol; 2001 Feb; 86(2):203-10. PubMed ID: 11258691
    [Abstract] [Full Text] [Related]

  • 12. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
    Noonan M, Leflein J, Corren J, Staudinger H.
    BMC Pediatr; 2009 Jul 13; 9():43. PubMed ID: 19594937
    [Abstract] [Full Text] [Related]

  • 13. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW, Prenner B, Berkowitz R, Galant S, Ramsdell J, Lutsky B.
    Ann Allergy Asthma Immunol; 2006 Apr 13; 96(4):533-40. PubMed ID: 16680923
    [Abstract] [Full Text] [Related]

  • 14. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
    Nayak AS, Banov C, Corren J, Feinstein BK, Floreani A, Friedman BF, Goldsobel A, Gottschlich GM, Hannaway PJ, Lampl KL, Lapidus RJ, Lawrence M, Lumry W, Munk Z, Pearlman D, Scardella AT, Schenkel EJ, Segal AT, Segall N, Silverman B, Shneyer L, Nolop KB, Harrison JE.
    Ann Allergy Asthma Immunol; 2000 Apr 13; 84(4):417-24. PubMed ID: 10795650
    [Abstract] [Full Text] [Related]

  • 15. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K, Noonan M, Silkoff PE, Uryniak T.
    Clin Ther; 2007 Jun 13; 29(6):1013-26. PubMed ID: 17692718
    [Abstract] [Full Text] [Related]

  • 16. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.
    Noonan M, Karpel JP, Bensch GW, Ramsdell JW, Webb DR, Nolop KB, Lutsky BN.
    Ann Allergy Asthma Immunol; 2001 Jan 13; 86(1):36-43. PubMed ID: 11206236
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 Jan 13; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 18. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.
    Karpel JP, Nelson H.
    Curr Med Res Opin; 2007 Nov 13; 23(11):2897-911. PubMed ID: 17922978
    [Abstract] [Full Text] [Related]

  • 19. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study.
    Krouse JH, Krouse HJ, Janisse JJ.
    Clin Drug Investig; 2009 Nov 13; 29(1):51-8. PubMed ID: 19067474
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety of mometasone furoate dry powder inhaler and budesonide Turbuhaler.
    Carlsson LG, Edsbäcker S.
    Eur Respir J; 2001 Jun 13; 17(6):1332-3. PubMed ID: 11491182
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.